Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2020 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Fourth Quarter and Full Year 2019 Financial Results

SOLANA BEACH, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
January 27, 2020 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Receives Notice of Allowance from USPTO for Gimoti™

SOLANA BEACH, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
January 23, 2020 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Enters Commercialization Agreement with EVERSANA Life Sciences for Gimoti™

EVERSANA to commercialize and distribute Gimoti in the U.S. EVERSANA to provide $5 million revolving credit facility upon FDA approval SOLANA BEACH, Calif. and CHICAGO, Jan. 23, 2020 (GLOBE...
January 21, 2020 08:30 ET | Source: Evoke Pharma, Inc.

FDA Accepts Evoke Pharma’s NDA Resubmission for Gimoti™

SOLANA BEACH, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal (GI)...
December 20, 2019 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Resubmits Gimoti™ New Drug Application to FDA

SOLANA BEACH, Calif., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
December 02, 2019 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Regains Compliance with Nasdaq Minimum Bid Requirement

SOLANA BEACH, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
November 13, 2019 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Granted 180-Day Extension by Nasdaq Regarding Minimum Bid Price

SOLANA BEACH, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
November 07, 2019 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Third Quarter 2019 Financial Results

SOLANA BEACH, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
September 17, 2019 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti™

SOLANA BEACH, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
August 08, 2019 05:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma to Resubmit Gimoti™ NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results

SOLANA BEACH, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...